Comparison of Pain Sensation During Single Use of Two Topical Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
NCT ID: NCT00869219
Last Updated: 2009-03-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
40 participants
INTERVENTIONAL
2009-03-31
2009-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of Acular LS Versus Nevanac for Pain Control in Eyes Undergoing PRK
NCT00347204
Comparison of the Efficacy of Nepafenac 0.1% and Nepafenac 0.3 % on Pain Associated With Intravitreal Injections
NCT03406689
Effect of Topical Nepafenac 0.1% on Pain Related to Intravitreal Injections
NCT02821390
Bromday Versus Nevanac Eye Drops to Control Pain Following Photorefractive Keratectomy
NCT01475877
Acular LS vs. Nevanac in Post op Inflammation Following Cataract Surgery
NCT00348582
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Nevanac
Nevanac
1 drop of NEVANAC at random eye
Acular LS
Acular LS
One drop of Acular LS
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Nevanac
1 drop of NEVANAC at random eye
Acular LS
One drop of Acular LS
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* No ocular surface pathology
* Eligible for cataract surgery
Exclusion Criteria
21 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Santa Casa de Misericordia de Santos
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Santa Casa de Misericordia de Santos
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gustavo T Grottone, MD, MBA,MSc
Role: PRINCIPAL_INVESTIGATOR
SCMS
João C Grottone, MD, MBA
Role: STUDY_CHAIR
SCMS
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Santa Casa de Misericordia de Santos
Santos, São Paulo, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SCMisericordiaSantos
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.